EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence

Shruthi H Iyer, Mary Y Yeh, Lauren Netzel, Molly G Lindsey, McKenzie Wallace, Kristina A Simeone, Timothy A Simeone iD

Nutrients · 2024

DOI: 10.3390/nu16040553 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Shruthi H Iyer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Neuroscience, Creighton University School of Medicine, Omaha, NE 68178, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Autism Spectrum Disorder, Epilepsy, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy often occurs with other neurological disorders, such as autism, affective disorders, and cognitive impairment. Research indicates that many neurological disorders share a common pathophysiology of dysfunctional energy metabolism, neuroinflammation, oxidative stress, and gut dysbiosis. The past decade has witnessed a growing interest in the use of metabolic therapies for these disorders with or without the context of epilepsy. Over one hundred years ago, the high-fat, low-carbohydrate ketogenic diet (KD) was formulated as a treatment for epilepsy. For those who cannot tolerate the KD, other diets have been developed to provide similar seizure control, presumably through similar mechanisms. These include, but are not limited to, the medium-chain triglyceride diet, low glycemic index diet, and calorie restriction. In addition, dietary supplementation with ketone bodies, polyunsaturated fatty acids, or triheptanoin may also be beneficial. The proposed mechanisms through which these diets and supplements work to reduce neuronal hyperexcitability involve normalization of aberrant energy metabolism, dampening of inflammation, promotion of endogenous antioxidants, and reduction of gut dysbiosis. This raises the possibility that these dietary and metabolic therapies may not only exert anti-seizure effects, but also reduce comorbid disorders in people with epilepsy. Here, we explore this possibility and review the clinical and preclinical evidence where available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicAutism Spectrum DisorderEpilepsyCognitive DysfunctionHumansDysbiosisDiet, Carbohydrate-RestrictedKetone BodiesMood Disorders

Stichwörter der Autor:innen

MCTPUFAaffective disorderautismcalorie restrictioncognitive impairmentketogenic dietketonelow glycemic indextriheptanoin

Substanzen

Ketone Bodies

Autor:innen und Institutionen

  • Department of Pharmacology & Neuroscience, Creighton University School of Medicine, Omaha, NE 68178, USA.

ORCID-Profile: Timothy A Simeone

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Iyer, S. H., Yeh, M. Y., Netzel, L., Lindsey, M. G., Wallace, M., Simeone, K. A., & Simeone, T. A. (2024). Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence. Nutrients. https://doi.org/10.3390/nu16040553

Vancouver

Iyer SH, Yeh MY, Netzel L, Lindsey MG, Wallace M, Simeone KA, et al. Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence. Nutrients. 2024. doi:10.3390/nu16040553

BibTeX
@article{Iyer2024,
  author = {Iyer, Shruthi H and Yeh, Mary Y and Netzel, Lauren and Lindsey, Molly G and Wallace, McKenzie and Simeone, Kristina A and Simeone, Timothy A},
  title = {Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16040553}
}
Kostenlos starten →